Creatine Kinase: A Protein for Muscle Contraction and Research

Target Name: Creatine Kinase

NCBI ID: P12939

Creatine Kinase

Other Name(s): CK

Creatine Kinase: A Protein for Muscle Contraction and Research

Creatine Kinase (CK), also known as Creatine Kinase isoform (CK-MB), is an enzyme that plays a crucial role in the process of muscle contraction. It is a protein that is found in muscle cells and is responsible for breaking down the chemical acetyl-CoA, which is a key component of muscle contraction.

CK is often used as a drug target or biomarker in the study of muscle physiology, exercise physiology, and myopathies. It is also used in the diagnosis of certain myopathies such as dystrophy and myonecrosis.

One of the main advantages of CK is its sensitivity to inhibitors, which makes it a useful target for drug development. CK inhibitors have been shown to be effective in treating a variety of myopathies, including dystrophy, myonecrosis, and certain types of cancer.

CK also has a high melon rate in the diagnosis of muscle damage and exercise-induced muscle damage. Its level increases in muscle after exercise, which can be used as a biomarker for muscle damage. Additionally, it can be used to predict the risk of muscle damage in individuals who are planning to engage in physical activity.

Another advantage of CK is its ability to cross the blood-brain barrier, which allows for its potential use as a therapeutic target for a variety of neurological disorders. This is an important feature for the development of new treatments for neurodegenerative diseases.

CK isoform (CK-MB) is a protein that is found in muscle cells and is responsible for breaking down the chemical acetyl-CoA, which is a key component of muscle contraction. It is often used as a drug target or biomarker in the study of muscle physiology, exercise physiology, and myopathies.

In addition to its use as a drug target, CK is also a useful biomarker for certain types of cancer. Its level increases in muscle after cancer treatment, which can be used as a biomarker for cancer recurrence.

CK is also used in the diagnosis of certain myopathies, such as dystrophy and myonecrosis. Its level increases in muscle affected by these conditions, which can be used as a biomarker for these conditions.

CK has also been used to study the effects of different muscle relaxants on muscle contractions. It is an important tool for researchers to study the mechanisms of muscle contraction and the effects of different muscle relaxants on muscle function.

In conclusion, Creatine Kinase (CK) is a protein that plays a crucial role in the process of muscle contraction. It is a drug target and biomarker and has a variety of applications in the study of muscle physiology, exercise physiology, and myopathies. Its sensitivity to inhibitors and its ability to cross the blood-brain barrier make it an attractive target for drug development. Additionally, its use as a biomarker for certain types of cancer and its ability to study the effects of different muscle relaxants on muscle function make it a valuable tool for researchers.

Protein Name: Creatine Kinase (nonspecified Subtype)

The "Creatine Kinase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Creatine Kinase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets